Fundación Pública Andaluza Progreso y Salud
OrganizationROR
Trials
Phase 4, Completed, 66 people, Dec 29, 2017
Phase 4, Completed, 163 people, Mar 11, 2016
Phase 3, Completed, 74 people, Feb 29, 2016
Phase 3, Terminated, 9 people, Jan 10, 2013
Phase 3, Status unknown, 104 people, Jan 10, 2013
Phase 3, Completed, 499 people, Jan 4, 2013
Funded papers
AP‐0105‐2016, Nov 3, 2023
Oct 2, 2023
PI 0234/14, Jul 1, 2022
PI 0234/14, Aug 14, 2021
PI 0234/14, Nov 1, 2019
Altered myogenesis and premature senescence underlie human TRIM32-related myopathy
Mar 1, 2019
Aug 11, 2016
Sources: openalex.org, pubmed.ncbi.nlm.nih.gov
Papers
Menopause-driven metabolomic shifts: unravelling cardiovascular disease risk in women
Endocrine reviews, Oct 1, 2026
International review of cell and molecular biology, Sep 22, 2026
Nutrients, Jul 15, 2026
BMJ open, Jun 10, 2026
Advanced science (Weinheim, Baden-Wurttemberg, Germany), Mar 16, 2026
European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity, May 25, 2025
The Impact of Menopause on Hypercholesterolemia and Comorbidities: A Population-Based Study
medRxiv, Dec 30, 2024
Aging cell, Jul 5, 2023
European geriatric medicine, Aug 6, 2020
Translational medicine @ UniSa, Jul 31, 2019
Annali dell'Istituto superiore di sanita, Oct 5, 2018
Annali dell'Istituto superiore di sanita, Oct 5, 2018